Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results

This publication has 13 references indexed in Scilit:

• Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes
  International Journal of Radiation Oncology*Biology*Physics, 2005
• The radiobiology of prostate cancer including new aspects of fractionated radiotherapy
  Acta Oncologica, 2005
• Fractionation and late rectal toxicity
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Comparison of rectal dose volume histograms for definitive prostate radiotherapy among stereotactic radiotherapy, IMRT, and 3D-CRT techniques
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Intrafractional stability of the prostate using a stereotactic radiotherapy technique
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules
  Radiotherapy and Oncology, 2003
• Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Is α/β for prostate tumors really low?
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate Cancer
  JAMA, 1997